Ibio Inc banner

Ibio Inc
NASDAQ:IBIO

Watchlist Manager
Ibio Inc Logo
Ibio Inc
NASDAQ:IBIO
Watchlist
Price: 2.135 USD -10.67%
Market Cap: $48m

Profitability Summary

Ibio Inc's profitability score is 14/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

14/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

14/100
Profitability
Score
14/100
Profitability
Score

Margins

Earnings Waterfall
Ibio Inc

Margins Comparison
Ibio Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Ibio Inc
NASDAQ:IBIO
53.8m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
390.9B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.7B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
192.8B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.6B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.8B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
78B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43B EUR
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Ibio Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Ibio Inc
NASDAQ:IBIO
53.8m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
390.9B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.7B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
192.8B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.6B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.8B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
78B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Ibio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate